• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Becton, Dickinson and Company (BDX)

    -NYSE
    139.81 0.62(0.44%) Dec 19, 4:04PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Becton, Dickinson and Company
    1 Becton Drive
    Franklin Lakes, NJ 07417
    United States - Map
    Phone: 201-847-6800
    Website: http://www.bd.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:30,619

    Business Summary 

    Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; and generic prefilled injectables. Its BD Diagnostics segment provides products for the collection and transportation of diagnostics specimens; and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections, and cancers. This segment’s products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood and tuberculosis culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company’s BD Medical segment offers research and clinical tools, such as fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. It also develops technologies that address biological analysis protocols, including library preparation of next generation sequencing and genotyping applications. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Investor Relations
    Employment
    Subsidiaries
    Search Yahoo! for:
    More on Becton, Dickinson and Company

    Corporate Governance 
    Becton, Dickinson and Company’s ISS Governance QuickScore as of Dec 1, 2014 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 5; Compensation: 3.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Vincent A. Forlenza BD, 61
    Chairman, Chief Exec. Officer and Pres
    2.19M1.28M
    Mr. Christopher R. Reidy , 57
    Chief Financial Officer and Exec. VP of Admin.
    282.00K0.00
    Mr. William A. Kozy , 62
    Chief Operating Officer and Exec. VP
    1.59M759.00K
    Mr. Jeffrey S. Sherman Esq., 59
    Sr. VP and Gen. Counsel
    1.09M1.11M
    Mr. Gary M. Cohen , 55
    Exec. VP
    1.11M1.86M
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders